CAPITOL COUNSEL LLC

Lobbying for BOEHRINGER INGELHEIM ANIMAL HEALTH US · Animal health.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Georgia · Senate · $50,000.00 income · posted Jul 18, 2025

Lobbying activity 2

Animals

Issues regarding FDA animal drug approval process.

Medical/Disease Research/Clinical Labs

Issues regarding FDA animal drug approval process.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.